MiFID review could have serious impact on OTC derivatives -

Sorry, you appear to have JavaScript disabled. Please enable
JavaScript to use this tool.

Find out how to enable it for your browser:

Internet Explorer 7 or 8

Click the Tools menu.
Select Internet Options.
Click the Security tab.
Click the Custom Level button.
Scroll down until you see the 'Scripting' section. Select the 'Enable' radio button for 'Active Scripting'.
Click the OK button.
Click the Yes button in the confirmation window.
Refresh this page.

Firefox 3.0

Click the Tools menu.
Select Options.
Click the Contents tab.
Select the 'Enable JavaScript' checkbox.
Click the OK button.
Refresh this page.

Refresh

Geraldine Lambe Monday, 31 January 2011

A proposed reform of MiFID could have a major impact on the OTC derivatives market, and it has been suggested that the authorities are paying only lip-service to consultation.

To continue reading, join our community and benefit from:

In-depth coverage across key markets
Comments from financial leaders and policymakers worldwide
Regional/country bank rankings and awards

Have an account? Sign In

Our Products:

MiFID review could have serious impact on OTC derivatives

To continue reading, join our community and benefit from: